Dutanol
Dutanol Price range: $ 40,00 through $ 556,00
Back to products
Duzela
Duzela Price range: $ 36,00 through $ 83,00

Dutas

Price range: $ 57,00 through $ 464,00

Dutas is an effective oral medication designed specifically for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men. The active ingredient works by inhibiting the 5-alpha reductase enzyme to reduce the levels of dihydrotestosterone, which helps shrink the enlarged prostate gland. Consistent use of this treatment can lead to significant improvements in urinary flow and a reduction in the urgency associated with BPH. Furthermore, it helps lower the long-term risk of developing acute urinary retention or requiring prostate-related surgery. This medication provides a dependable approach to managing prostate health and restoring comfort to daily activities.

Active substance: Dutasteride
SKU: Dutas Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Dutas belongs to a class of medications called 5-alpha reductase inhibitors, designed to target the enzymatic pathways involved in androgen metabolism. It is prescribed in the United States under federal prescription guidelines for managing lower urinary tract symptoms associated with benign enlargement of the prostate gland.

Because Dutas exerts systemic effects on hormone conversion, proper administration under the supervision of a licensed healthcare provider is essential for therapeutic efficacy and safety. Patients undergoing treatment should remain aware of its administration requirements, monitoring protocols, and pharmacological properties.

Key Product Summary

Attribute Specification
Drug name Dutas
Active ingredient Dutasteride
Therapeutic class 5-alpha reductase inhibitor
Dosage form Oral soft capsule
Route of administration Oral
Primary purpose Management of Benign Prostatic Hyperplasia (BPH)
Prescription status Prescription (Rx) only

How the drug works

Dutas contains dutasteride, a synthetic 4-azasteroid compound that acts as a competitive, selective inhibitor of both type 1 and type 2 5-alpha reductase isoenzymes. These intracellular enzymes are responsible for converting testosterone into dihydrotestosterone (DHT), the primary androgenic hormone driving prostate tissue proliferation and hypertrophy.

By inhibiting both isoenzymes, Dutas rapidly reduces circulating and intraprostatic concentrations of DHT by more than 90%. Suppressing DHT production leads to a progressive reduction in total prostate volume, which helps relieve physical obstruction at the bladder neck, improves urinary peak flow rate, and decreases long-term complications associated with glandular enlargement.

Main uses

Dutas is indicated for the treatment of symptomatic Benign Prostatic Hyperplasia (BPH) in adult men with an enlarged prostate. Clinical goals include reducing urinary frequency, improving stream force, lessening the risk of acute urinary retention, and reducing the potential necessity for surgical intervention related to BPH. It may be prescribed as monotherapy or in combination with an alpha-adrenergic antagonist such as tamsulosin.

Off-Label Use Notice: The use of Dutas for androgenic alopecia (male pattern hair loss) is considered an off-label application in the United States and is not approved by the FDA for this specific indication. Patients considering off-label use must discuss potential risks and benefits thoroughly with a qualified physician.

Dosing schedule

The standard dosage for adult males is 0.5 mg taken orally once daily. Dutas capsules should be ingested whole with a full glass of water. Capsules must not be chewed, opened, or crushed prior to swallowing, as direct contact with the internal liquid contents can cause severe irritation of the oropharyngeal mucosa.

The medication can be taken with or without food. Maintaining a consistent daily dosing routine helps ensure stable plasma concentrations of the active substance over time. Adjustments for mild renal impairment or advanced age are generally unnecessary, though individual guidance from a physician must always be followed.

What happens in the body

Following oral administration of a single 0.5 mg dose, peak plasma concentrations of dutasteride are achieved within 1 to 3 hours. The absolute bioavailability of the drug is approximately 60%. Dutasteride exhibits extensive plasma protein binding, primarily binding to albumin and alpha-1 acid glycoprotein at rates exceeding 99%.

Metabolism occurs heavily in the liver via the cytochrome P450 enzyme system, specifically involving CYP3A4 and CYP3A5 pathways. Dutasteride features a long elimination half-life of approximately 5 weeks at steady-state. Because of this extended half-life, serum concentrations remain detectable for up to 4 to 6 months after treatment is discontinued.

Compatibility with other medicines

Because dutasteride undergoes hepatic metabolism via CYP3A4 and CYP3A5 enzymes, concomitant administration of strong or moderate CYP3A4 inhibitors may increase systemic exposure to the drug. Common interacting agents include ritonavir, ketoconazole, itraconazole, diltiazem, and verapamil. While dose adjustments are not routinely established, monitoring for potential adverse reactions is recommended during co-administration.

Dutas can be administered alongside alpha-blockers like tamsulosin, as clinical trials demonstrate complementary mechanisms without significant pharmacokinetic interactions. However, patients should always inform their healthcare provider of all prescription medications, over-the-counter drugs, and herbal supplements currently in use.

Adverse reactions

Adverse reactions associated with Dutas primarily relate to anti-androgenic effects. Patients may experience one or more of the following side effects during therapy:

  • Erectile dysfunction or impotence
  • Decreased libido (sex drive)
  • Ejaculation disorders (such as reduced ejaculate volume)
  • Gynecomastia (breast tissue enlargement or tenderness)
  • Mild dizziness or headache

In clinical trials, the incidence of sexual side effects was highest during the first year of treatment and typically decreased with continued therapy. If any side effect becomes severe, persistent, or bothersome, patients should seek prompt medical advice.

Before you take it

Dutas carries strict precautions regarding specific populations and clinical parameters:

  • Pregnancy and Handling: Dutas is strictly contraindicated in women who are pregnant or may become pregnant. The active drug can be absorbed through the skin and poses a severe risk of fetal harm, specifically abnormal development of external genitalia in male fetuses. Leaking or damaged capsules must never be handled by pregnant women.
  • Blood Donation: Men taking Dutas must refrain from donating blood while on therapy and for at least 6 months following their final dose. This waiting period prevents transfusing blood containing residual dutasteride to female recipients of childbearing age.
  • Prostate Cancer Screening: Dutasteride reduces serum Prostate-Specific Antigen (PSA) levels by approximately 50% after 6 months of treatment. Physicians must establish a new baseline PSA value to interpret future screening tests accurately and monitor for high-grade prostate cancer risk.

First days of treatment

When starting Dutas therapy, patients should understand that symptomatic relief is not immediate. Because prostate involution requires sustained suppression of dihydrotestosterone levels, early days of treatment primarily establish systemic drug accumulation. Noticeable improvements in urinary stream velocity or reductions in nocturnal awakening usually require several weeks to months of continuous daily compliance.

Signs of improvement

Therapeutic response to Dutas is monitored over time through clinical evaluations and patient reporting. Positive signs of improvement include a reduced frequency of urination, less difficulty initiating a stream, reduced urgency, and a feeling of complete bladder emptying. Physicians may also evaluate progress using standardized symptom scoring scales or objective ultrasound measurements of prostate volume.

If you skip a dose

If a dose of Dutas is missed, it should be taken as soon as remembered on that same day. If it is almost time for the next scheduled dose, the missed capsule should be omitted, and the regular dosing schedule resumed. Patients must not double up on capsules or take extra medicine to make up for a missed dose.

What to avoid while taking it

There are no restricted dietary interactions associated with Dutas, and the medication may be taken with or without food. Moderate consumption of alcohol does not interfere directly with the drug’s metabolic pathway; however, excessive alcohol consumption can independently irritate the bladder and aggravate lower urinary tract symptoms.

Common questions

How long does it take for Dutas to improve urinary symptoms?

While hormonal suppression begins shortly after initiating therapy, clinical reduction in prostate size occurs slowly. Most patients observe initial symptom relief within 3 to 6 months, although maximum therapeutic benefit may require up to 12 months of daily adherence.

Why are women advised not to touch Dutas capsules?

Dutasteride can be absorbed directly through the skin. If absorbed by a woman carrying a male fetus, the anti-androgenic action of the drug can interfere with normal fetal genital development. Intact soft capsules prevent contact, but damaged or leaking capsules must be avoided entirely.

Does Dutas permanently cure an enlarged prostate?

Dutas manages the symptoms and physical progression of benign prostatic hyperplasia by suppressing DHT production. It does not permanently cure the condition. Stopping the medication usually results in a gradual return of baseline DHT levels and eventual re-growth of prostate tissue.

How does Dutas affect blood tests for prostate monitoring?

Dutas lowers serum PSA concentrations by roughly 50% after steady-state levels are achieved. Doctors account for this baseline shift when interpreting PSA results to ensure accurate ongoing screening for prostate health.

Is Dutas approved for treating hair loss in the United States?

No. In the United States, Dutas (dutasteride) is FDA-approved only for treating benign prostatic hyperplasia. Its use for male pattern hair loss is off-label and requires direct medical evaluation and oversight from a prescribing physician.

In accordance with FDA guidelines and federal regulations.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

0.5mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

Ενεργός Ουσία